Antidepressant use during pregnancy: current controversies and treatment strategies
- PMID: 19661762
- PMCID: PMC2749677
- DOI: 10.1097/GRF.0b013e3181b52e20
Antidepressant use during pregnancy: current controversies and treatment strategies
Abstract
The treatment of depression during pregnancy is both a common and complex clinical challenge. The decision to expose the fetus to antidepressant medication during pregnancy must be weighed against the risks of untreated maternal depression to both mother and fetus. Maternal depression during pregnancy has been associated with increased rates of preterm birth and maternal substance use. The safety of antidepressant use during pregnancy seems to be largely reassuring but there remain 2 areas of controversy including neonatal withdrawal syndrome and primary pulmonary hypertension of the newborn. Individualized treatment recommendations based on the patient's history are essential to optimize outcomes.
References
-
- Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004;191(2):398–407. - PubMed
-
- Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295(5):499–507. - PubMed
-
- Cohen LS, Nonacs RM, Bailey JW, et al. Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study. Arch Womens Ment Health. 2004;7(4):217–221. - PubMed
-
- O'hara MW, Swain AM. Rates and risk of postpartum depressionΓÇöa meta-analysis. International Review of Psychiatry. 1996;8(1):37–54.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
